Oral Squamous Cell Carcinoma and Hyperkeratotic Lesions With BRAF Inhibitors

Br J Dermatol. 2015 Jun;172(6):1680-1682. doi: 10.1111/bjd.13610. Epub 2015 Apr 19.

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / adverse effects*
  • Carcinoma, Squamous Cell / chemically induced*
  • Humans
  • Imidazoles / adverse effects*
  • Indoles / adverse effects*
  • Leukoplakia, Oral / chemically induced*
  • Melanoma / drug therapy
  • Middle Aged
  • Mouth Mucosa
  • Mouth Neoplasms / chemically induced*
  • Mutation / genetics
  • Oximes / adverse effects*
  • Proto-Oncogene Proteins B-raf / genetics
  • Skin Neoplasms / drug therapy
  • Sulfonamides / adverse effects*
  • Vemurafenib

Substances

  • Antineoplastic Agents
  • Imidazoles
  • Indoles
  • Oximes
  • Sulfonamides
  • Vemurafenib
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
  • dabrafenib